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Sary We have previously reported that an increase in the production of immunosuppressive prostaglan-
din E2 by a QR tumour (QR-32) is accompanied by progressive growth of the tumour in syngeneic C57BL/6
mice. In order to determine what kinds of cell and factor(s) enable QR-32 cells to promote PGE2 production,
we investigated the amounts of PGE2 in the supematant of QR-32 cells by co-culturing them with various
anti-tumour effector ces. Signntly high lees of PGE2 production were observed when the QR-32 cells
were co-cultured with lymphokine-activated killer (LAK) cells, natural killer (NK) cells, polymorphonuclear
(PMN) kucocytes and stpococcal preparation (OK432)-activated or resident peritoneal macrophages
(activated and resident macrophages). On the other hand, PGE2 production was not increased when QR-32
cells were co-cultured with cytotoxic T lymphocytes (CTLs) specific to QR-32 cells. The high levels of PGE2
production were partially or totally inhibited by the presence of radical scavengers such as superoxide
dismutase (SOD), catalase and mannitol, although the cytotoxicty of LAK cells was not We also exposed
QR-32 cells to human recombinant cytokines and the growth factors which are produced when anti-tumour
effector cells come in contact with tumour cells. Signifiant PGE2 production by QR-32 cells was observed
when the cells were treated with interferon alpha (IFN-a), tumour necrosis factor alpha (TNF-x) and
transforming growth factor beta (TGF-F) (all P<0.001). These results suggest that oxygen radicals produced
by anti-tumour effector cells and inflammatory cytokines provoke QR-32 cells to produce large amounts of
immunosuppresiv PGE2.
Prostaglandins, especially those of the E series, are well-
known endogenous immunosuppressive factors. Prostaglan-
din E2 (PGE2) inhibits the production of interleulin 2 (IL-2)
by T cells and inhibits T-cell proliferative responses to
mitogens (Walker et al., 1983; Young & Dizer, 1983).
Tumour-derived PGE2 promotes the in vivo growth of
tumour cells by suppressing the host anti-tumour immune
defences (Catalona & Chretien, 1973; Jessup et al., 1976;
Anderson et al., 1981). When prostaglandin levels in tumour-
bearing mice are reduced by the oral administration of an
inhibitor of PGE2 synthesis, indomethacin, or by use of
antibodies against PGE2, immunosuppression is also reduced
and tumour development is significantly diminished (Lynch
& Salomon, 1979; Young & Dizer, 1983; Young & Knies,
1984; Okada et al., 1990). These studies reveal an evident
parallelism between the level of PGE2 production and the
growth and malignant progression of tumour cells (Rolland
et al., 1990).
We have previously reported that a clone (QR-32 cells)
derived from a cultured mouse fibrosarcoma, BMT-l1 cl-9,
spontaneously regresses in normal syngeneic C57BL/6 mice
(Ishikawa et al., 1987a, Okada et al., 1990). We considered
that, because PGE2 suppressed the anti-tumour effector cell
induction at the site of tumour implantation in the
tumorgenic parental BMT-11 cl-9 cells, the regression of
QR-32 cells was likely to be due to a decrease in the produc-
tion of PGE2 (Okada et al., 1990)_ We have also observed
that oxygen radicals produced by host cells reactive to
foreign bodies such as gelatin sponge augment the produc-
tion of PGE2 by QR-32 cells during co-culture in vitro. The
enhanced production of immunosuppressive PGE2 facilitates
the progressive growth of tumours in normal mice when they
are given a subcutaneous injection of mixtures of host cells
reactive to gelatin sponge and QR-32 cells (Okada et al.,
1992). In our mouse tumour model, PGE2 acts not only to
augment the in vivo growth of tumour cells but also as a
positive factor for the chemotaxis of tumour cells, as well as
enhancing QR-32 cell-derived progressor tumour cell migra-
tion and dissemination (Young et al., 1991). In the present
study, we have examined what kinds of anti-tumour effector
cell are able to promote in vitro PGE2 production by QR-32
cells, and have attempted to determine whether oxygen
radicals or cytokines are involved in the enhancement of
PGE2 production by tumour cells.
Materials and
Twnour cells
The origin and characteristics of the tumour cells used in the
experiments have been described previously (Ishikawa et al.,
1987a,b; Okada et al., 1990). Briefly, after exposure of the
tumorigenic mouse fibrosarcoma BMT- 11 cl-9 cells to
quercetin and cloning by limiting dilution, we were able to
obtain QR-32 clone cells which spontaneously regress in
normal syngeneic C57BL/6 mice (Ishikawa et al., 1987a).
In our previous study, we concluded that the in vivo regres-
sion of QR-32 cells is mainly due to a decrease in the
production of immunosuppressive PGE2 as compared with
the tumorigenic parent BMT-I 1 cl-9 cells, in which the induc-
tion of anti-tumour effector cells is suppressed at the site of
tumour implantation (Okada et al., 1990). We found that the
threshold level of POE2 production necessary to suppress
host immune reactivity in vivo is equivalent to approximately
6,000pgml-' of medium in vitro, a value which was pro-
duced by 1 x 104 tumour cells during a 48 h culture (Okada
et al., 1990, 1992).
Reagents
Recombinant human superoxide dismutase (SOD) was a
generous gift from Nippon Kayaku (Tokyo, Japan). Catalase,
mannitol, indomethacin and MTT [3-(4,5-dimethylthiazol-2-
yl)-2, 5-diphenyl tetrazolium bromide] were purchased from
Sigma (St Louis, MO, USA). Cytokines and growth factors
were kindly provided by the companies in parenthesis;
human r-TNF-a (Dainihon, Japan), human r-IL-2 (Shionogi,
Japan), human r-EGF, human IL-1p, human TGF-a and -p
(Otsuka, Japan), human rG-CSF (Kirin Beer, Japan), mouse
r-IFN-x A/D (Japan Roche) and human bFGF (Takeda,
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Japan). IL-6 was a kind gift from Professor T. Hirano,
Osaka University. OK-432, the penicillin-treated Su strain of
Streptococcus pyogenes, was donated by Chugai (Tokyo), of
which the clinical unit is expressed as KE (1 KE = 0.1 mg
dry weight of bacteria).
Culture conditions
QR-32 cells and anti-tumour effector cells were co-cultered in
Eagle's minimum essential medium supplemented with 8%
fetal calf serum (inactivated at 56-C for 30min), sodium
pyruvate, non-essential amino acids and L-glutamme, at
37C, in a humidified 5% carbon dioxide-95% air mix-
ture.
Preparation ofanti-tumour effector cells
Cytotoxic T lymphocytes (CTLs) specific to QR-32 cells were
obtained from a 5 day mixed lymphocytes and tumour cell
culture (MLTC). LAK cells were obtained from a 6 day
culture of normal splenocytes with r-IL-2 (1,000 Uml-'). We
used Percoll gradients (Pharmacia LKB Biotechnology, Upp-
sala, Sweden) to isolate NK cells after centrifugation at
1,800 r.p.m. for 40 min from the normal splenocytes that
floated in the interfaces between densities of 1.060 and 1.070
(Bossiet et al., 1981; Mizobe et al., 1982). As our group has
previously reported, more than 90% of the spkenocytes in
BMT-l1 cl-9 tumour bearers are PMN leucocytes (Ishikawa
et al., 1987b). Mice were injected i.p. with the 0.4 KE strepto-
coccal preparation, OK432, which activates peritoneal
macrophages (Hojo & Hashimoto, 1981; Kawaguchi et al.,
1983). Seven days later, peritoneal exudate cells were col-
lected, seeded into plastic plates and incubated for 1 h.
Plastic-adherent cells were used as activated macrophages.
Resident macrophages were collect by the same procedure
as the activated macrophages except for the OK432 injection.
Details of the induction of anti-tumour effector cells have
already been reported (Okada et al., 1990).
"'In-oxune-release assay
Target QR-32 tumour cells were labelled with 0.1 mCi of
"'In-oxine (Nihon Medi-Physics, Japan). Approximately
1 x 10' target cells were distributed into the wells of 96-well
round-bottom microplates, to which various anti-tumour
effector cells were added (effector-to-target cell ratios ranging
from 200:1 to 1:1). Assays were performed in triplicate.
After 48 h incubation, the plates were centrifuged, and the
radioactivity of the supernatant was measured with a gamma
counter. Specific cytotoxicity was caculated by the following
formula, where a is the value of "'In release due to the
cytotoxicity of the effectors, b is the total "'In release caused
by treatment with 1 M hydrochloric acid and c is the value of
spontaneous release from target tumour cells incubated with
medium alone:
a-c
Specific 'In release (%) =-x100
b-c
The details of these assays have been described elsewhere
(Kawata et al., 1990).
"Cr-release assay
Target QR-32 cells were labelled with 0.1 mCi of5"Cr-sodium
chromate (New England Nuclear, Boston, MA, USA). The
labelled tumour cells were co-cultured with LAK cells for
6 h. The speific cytotoxicity and the procedures were the
same as those indicated for the "'In-oxine-release assays. The
details of these assays have been described elsewhere (Okada
et al., 1990).
MUT assay
Approximately 1 x 10' QR-32 cells were seeded into the wells
of a 96-well flat-bottomed plastic plate with or without
cytokines or growth factors. After 48 h incubation, 50yig
IO l` MTT was added and further incubated for 3h. A
150 ILI aliquot of dimethyl sulphoxide (DMSO) was added
and the plate was read on a micro-ELISA reader (Easy
Reader EAR 340, Labo Science, Japan), using a test
wavelength of 540 nm with a reference wavelength of 630 nm
(Mosmann, 1983).
Preparation and radioimmunoassayfor PGE2
Approximately 1 x 10' QR-32 cells were cultured with or
without anti-tumour effector cells at various effector-to-
tumour cell ratios in 24 well plastic plates in 2 ml of medium
per well for 48 h, after which the supernatants were
harvested. PGE2 production by QR-32 cells after co-culture
with various doses of cytokines and growth factors was
measured by the same procedure as the one described above.
Supernatants were stored below - 70-C until required for the
assay for PGE2. The amounts of PGE2 in the samples were
determined by a commercially available radioimmunoassay
kit (New England Nuclear, Boston, MA, USA). Determina-
tions were carried out in triplicate and the mean and stan-
dard deviations were obtained. The details of this assay have
been described previously (Okada et al., 1990).
Statistical analysis
The signifi of the differences in the PGE2 production
was caculated by the Student's t-test. All experiments were
repeated two or three times and the representative data were
derived from one out of at least two experiments with similar
results.
Res
Cytolysis ofQR-32 cells by various anti-tumour effector cells
We examined the cytotoxicity ofvarious anti-tumour effector
cells such as CTL, LAK, NK, PMN and activated/resident
macrophages against "'In-oxine-labelled QR-32 cells for
48 h. We observed that these anti-tumour effector cells lysed
QR-32 cells to various degrees when the effector-to-target cell
(El/) ratios ranged from 200:1 to 1:1 (Table I).
Increasedproduction ofprostaglandin E2 by QR-32 cells after
co-culture with vwarious anti-twnour effector cells
We co-cultured QR-32 cells (1 x 10') and each anti-tumour
effector cell at various E/T ratios and measured the amounts
ofPGE2 (Figure 1). Sinificntly high levels ofPGE2 produc-
tion were observed when QR-32 cells were co-cultured with
various anti-tumour effector cells even at low E/T ratios,
whereas CTL specific to QR-32 cells did not induce PGE2
production. The amounts of PGE2 production caused by
anti-tumour effector cells alone varied. QR-32 cells by
themselves produced less than 2,550 pg ml-' PGE2. Since
individual anti-tumour effector cells lysed QR-32 cells to
various extents (Table I), and since PGE2 production
depended on the number oftumour cells, we compared PGE2
production at the E/T ratio at which an equal number of
surviving tumour cells remain after co-culture with the indi-
vidual anti-tumour effector cells. The data are summarised in
Table H, in which we show the E/T ratios that produced
about 30% lysis ofthe QR-32 cells. We record PGE2 produc-
tion by anti-tumour effector cells alone, by tumour cells
alone and by anti-tumour effector cells alone plus tumour
cells alone (expected value) and PGE2 production during
co-culture of tumour cells with anti-tumour effector cells
under the same conditions (observed value). The results show
that the observed value of PGE2 production caused by the
co-culture of tumour cells with LAK, NK and PMN cells
and by activated/resident macrophages is significantly greater
than the additive PGE2 production (expected value) caused
by the tumour cells and the corresponding anti-tumourANTI-TUMOUR EFFECTORS INDUCE PGE: PRODUCTION BY TU-NIOUR CELLS 235
Table I Cytolysis of QR-32 cells by cytotoxic T lymphocytes (CTLs). Ilmphokine-activated killer (LAK
cells. natural killer CNK) cells. polymorphonuclear (PMN) leucoc-tes and acti-ated resident macrophages
Specific citoli-sis hi effector cells -
E T .4criiated Resident
ratio^ CTLo LAK' vKj P1VN macrophazesg macrophages'
200:1 54.9 06 NT NNT 29.8 1.4 NT NNT
100:1 66.2 0.6 825 0O. 61.9 1.2 I5.3 1.0 80.8 2'.1 NNT
50:1 64.9 1.2 61.5z1.1 5 I.8z3 135-2I 61. _1. 11.3 1.4
25:1 59.6 0.8 44.1 2'.9 51.63- 1 18.8 1.3 50.3 '2.1 10.'3 14
10:1 34.4 _ 12 ' _ 2 24.0 _ 28 15.5 1 3 15.9 0. .9- 1.
5.1 .3 10 24.2 2.2 11.5 1.- 15.2 1.9 N-T NT
I11 2 .25 1 2 10.5 0.' 5z1 14.-23. 8.8z 1.9 NT
'The cvtolvtic activity A-as assessed in a 48 h In-release assav against 1 x 10' QR-32 cells. Determinations
w-ere carried out in triplicate "Effector-to-target cell ratio. Immunised splenocytes w-ere stimulated by MLTC
A-ith the same QR-32 cells. 'Normal splenocvtes w-ere cultured for 6 davs w-ith 1.000 U ml- human r-IL-2
NK cells A-ere isolated by Percoll gradients from normal splenocytes. PMN- leucocytes A-ere obtained from
the spleen cells u-ith granulocytosis in mice beanng tumours. 8Mice were injected i.p. with OK432 (0.4 KEL.
Seven days later. peritoneal exudate cells were collected and seeded into plastic plates and incubated for 1 h.
Cytotoxic activitv of activated macrophages A-as assessed using these plastic-adherent cells. 'Resident
macrophages were collected by the same procedure as described in footnote g. except for the injection w-ith
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Figure 1 Increased production of prostaglandin E: by QR-32 cells after co-culture With *-arious anti-tumour effector cells. P.GE-
production was obserxed w-hen 1 x 10' QR-32 cells were co-cult-red with anti-tumour effector cells at various effector-to-tumour
cell ratios for 48 h. PGE- production was indicated as QR-32 cells co-cultured with anti-tumour effector cells ( _ ). anti-tumour
effector cells alone ( = ) and QR-32 cells alone ( M ). Determinations were camred out in triplicate and the mean and standard
deviation were obtained.236 F. OKADA et al.




cells effector Twnour Tumour + anti-tumour
co-culture cell cell E/T effector cells
Xithb alone alone ratioc EJxpectedd Observed
CTLs 2,650 132 1,367± 116 10:1 4,016± 29 3,083± 76
LAK 617± 29 1,550± 132 10:1 2,166± 153 25,000± Of
NK 1,150 132 1,583 76 10:1 2,717 ± 76 18,500± 866c
PMN 4,100 361 1,583 76 200:1 5,683 ± 431 25,000 0± O
Activated 4,150 180 1,700 100 10:1 5,850±278 15,333± 1,155'
macrophages
Resident 1,767 252 1,633 153 50:1 3,400± 361 8,933 ± 603'
macrophages
'PGE2 production was observed when 1 x 10' QR-32 cells were co-cultured with effector cells
at an E/T ratio which produced about 30% lysis of the QR-32 cells. PGE2 levels in supernatants
obtained from co-cultures in 24-well plastic plates for 48 h. 'The methods for the induction and
coUlection of each effector cell are described in Table I, footnotes c-h, and in the Materials and
methods section. cEffector-to-target ceUl ratio. dExpected values were calculated from the additive
production of PGE2 by the tumour and effector cells. 'Significant increase in the observed
production of PGE2 by the co-cultured cells was observed as compared with the expected values
(P <0.001).
effector cells (P<0.001). On the other hand, PGE2 produc-
tion by co-culture of tumour cells with CTLs is almost equal
to the expected value. Not only QR-32 cells but also tumori-
genic parental BMT-11 cl-9 cells, which produce large
amounts of PGE2 by themselves, can be converted so as to
produce much greater amounts ofPGE2 after co-culture with
anti-tumour effector cells (data not shown).
Inhibition ofthe increase in PGE2production during QR-32
cell co-culture with anti-tumour effector cells in thepresence of
radical scavengers
We examined the effect of radical scavengers on the PGE2
production of QR-32 cells enhanc by co-culturing them
with anti-tumour effector cells (Figure 2). Superoxide dis-
mutase (SOD, 300 U ml-) inhibited the increase in PGE2
production after QR-32 cells were co-cultured with LAK and
PMN cells (P<0.001 and P<0.005, respectively), whereas
SOD did not inhibit PGE2 production significantly after
being co-cultured with NK cells or activated/resident mac-
rophages. In the presence of catalase (20,000Uml-') and
mannitol (5 x 10-2 M), PGE2 production was significntly
inhibited when tumour cells were co-cultured with anti-
tumour effector cells. As a positive controL PGE2 production
was also inhibited after we added indomethacin (10-6 M), an
inhibitor of prostaglandin synthesis.
Effects ofoxygen radicalscavengers on the cytolysis ofQR-32
cells during co-culture with lymphokine-activated killer cells
Since LAK cells produce various species of oxygen radicals
in our system (Figure 2), and sinc QR-32 cells have been
shown to be highly sensitive to LAK cells even in a 6h
5'Cr-release assay (Olkada et al., 1990), we next examined the
effects of oxygen radicals produced by LAK cells on the
cytolysis of QR-32 cells (Table III). The LAK cells' kIilling
activities were not significantly reduced during co-culture
with SOD, catalase and mannitol. No cytotoxic activity by
radical scavengers on QR-32 cells was observed.
Increasedproduction ofprostaglandin E2 after exposure of
QR-32 cells to IFN-x AID, TNF-c and TGF-P
We measured the PGE2-producing activity and enhancement
of cell growth of QR-32 cells after their co-culture with
various recombinant cytokines and growth factors. IL-1p,
IL-2, IL-6, G-CSF, IFN-z A/D, TNF-a, TGF-a and -P,
bFGF and EGF were diluted to 10-fold dilutions from high
concentrations and 1 x 104 QR-32 cells were exposed to each












Fige 2 Inhibition of the increase in PGE2 production during
co-culture of QR-32 cells with anti-tumour effector cells in the
prsence of radical scavengers. Approximately I x 101 QR-32
cells were co-cultured with vaious anti-tumour effector cells with
or without the oxygen rdical scavengers SOD (300 U ml-'),
catalase (20,000 Uml') or mannitol (5 x 10-2 M) for 48 h. Each
E/T ratio which produced about 30% lysis of QR-32 cells was
determinedr Determinations were carried out in triplcate and the
mean and standard deviation were obtained. *P<0.001, "P<0.005; NS, not significant vs PGE2 production by the corres-
ponding no-scavenger group. -, No scavengers; M, SOD;,
, catalas; , mannitol, L, indomethacin; ,
effector alone.
culture supernatants. Table IV shows typical data from one
of at least two experiments. IFN-a A/D, TNF-x and TGF-P
induced signifintly inc d PGE2 production by the QR-
32 cells (P<0.001). Cell growth was inhibited by as much as
59.8% and 61.0% when QR-32 cells were exposed to 100 and
lOngml-' IFN-x A/D respectively, by 54.8% and 77.7%
when the cells were exposed to 1,000 and 100 U ml-' TNF-x
resPectively and by 88.7% when the cells were exposed to
IOngml-' TGF-P, all as compared with the growth of un-
treated QR-32 cells (100%). Other cytokines which did not
induce QR-32 cells to produce large amounts of PGE2 did
not inhibit the growth of QR-32 cells either.
In this study, we have been able to demonstrate that prosta-
glandin E2 (PGE2) production by QR-32 cells is augmented
when the tumour cells are co-cultured with various anti-
tumour effector cells at various effector-to-tumour cell ratios,
with the exception of cytotoxic T lymphocytes (CTLs)
specific to the tumour cells. Enhad PGE2 production byANTI-TUMOUR EFFECTORS INDUCE PGE2 PRODUCTION BY TUMOUR CELLS 237
TAe M Effects of oxygen radical scavengers on the cytolysis of
QR-32 cells after co-culture with lymphokine-activated kilIer cells
Specific cytolysis of QR-32 cells after
Treated co-culture with (%)b
with' LAK Nothing
Nothing 68.9 6.4
SOD 69.7 5.6 0.0 ± 0.0
Catalase 66.7 5.2 0.3 ± 0.3
Mannitol 64.7 1.6 0.0 ± 0.0
'Each cell type was plated into wells in a 96-well plastic plate with
or without oxygen radical scavengers; SOD (300 Uml-'), catalase
(20,000 U ml-') and mannitol (5 x 10-2 M) for 6h. "The cytolytic
activity was assessed in a 6 h 5"Cr-release assay against QR-32 cells
with an E/T ratio of 50:1. Determinations were carried out in
triplicate.
Tabie IV PGE, production and growth of QR-32 cells after
exposure to various cytokines and growth factors
QR-32 cells Cell
co-cultured Concentration PGE2 productione growthb
with (ml-') (pg m ) (%
IFN-a A/D 100 ng 10,667 ± 1,155c 59.8
10 ng 8,733 231c 61.0
TNF-a 1,000 U All >25,000c 54.8
100 U All >25,000c 77.7
TGF-0 10 ng 8,400 173' 88.7
1 ng 4,%66 252' 101.7
IL-l1 100 ng 2,633 ±252d 106.5
10 ng 2,617 16Id 104.1
IL-2 1,000 U 2,550 50d 99.5
100 U 2,433 ± 58d 100.0
IL-6 50 U 2,533 ± 116d 95.0
5 U 2,517 + 76d 103.0
G-CSF 2,500 pg 2,483 76d 102.5
250 pg 2,450 87d 101.7
TGF-a 10 ng 2,833 ± 153d 93.9
1 ng 2,483 176d 105.0
bFGF 500 ng 2,533 + 58d 107.0
100 ng 2,517 ± 104d 102.5
EGF 1,000 ng 2,467 ± 58d 102.4
100 ng 2,417 ± 104d 100.0
None - 2,550 +150 100.0
Medium alone - All <250 -
'Approximately 1 x 10' QR-32 cells were plated into weUls in a
24-well plastic plate with or without cytokine or growth factor. PGE2
production in culture supernatant after 48 h was measured. bPer cent
cell growth when compared with non-treated cell growth assessed by
48 h MUT assay. 'P <0.001. dNot significant vs PGE2 production by
QR-32 cells alone.
tumour cells is considered to be an important mechanism for
facilitating tumour cell escape from host immune surveil-
lInmce. We have previously reported that QR-32 cells derived
from tumorigenic BMT-l1 cl-9 cells, which produce large
amounts of PGE2, find it hard to grow progressively in
normal syngeneic mice because of a decrease in the produc-
tion of PGE2 (Okada et al., 1990). We have also observed
that PGE2 acts not only as an immunosuppressive factor but
also as a positive factor for the chemotactic and motile
behaviour of tumour cells (Young et al., 1991). These
previous observations revealed that enhanced PGE2 produc-
tion by tumour cells results in the malignant progression of
the tumour cells (Okada et al., 1992). QR-32 cells produce
large amounts of PGE2 when the tumour cells have been
co-cultured with foreign body-reactive cells (Okada et al.,
1992). In this study, we therefore attempted to determine
which cell type of the anti-tumour effector cells is involved in
the induction of QR-32 cell progression.
At the present time, we have not established why QR-32
cells co-cultured with CTLs do not induce PGE2 production
under the same conditions as co-culturing with other effector
cells. One possible explanation is that CITLs may completely
Iill all tumour cells that bind specfically to tumour
antigen(s) (Thozz, 1993; Yasumura et al., 1993). This would
mean that only those tumour cells which do not make con-
tact with CTLs can survive. On the other hand, although the
antigen non-specific anti-tumour effector cells are able to kill
a large proportion of the QR-32 cells, they would also affect
the surviving tumour cells. We speculate, therefore, that sur-
viving QR-32 cells, after contact with antigen non-specific
anti-tumour effector cells, are converted so as to produce
large amounts ofPGE2. This speculation is supported by our
finding that only cytotoxic cytokines (IFN-a, TNF-4 and
TGF-P) enhanced PGE2 production by QR-32 cells (Table
MV). Our preliminary data show that the surviving QR-32
cells, after in vitro co-culture with NK cells and LAK cells
were converted to tumorigenic tumours in normal syngeneic
mice after subcutaneous injection (data not shown). We
believe that, under appropriate conditions, anti-tumour
effector cells within tumour tissues might induce malignant
progression of tumours through the enhanced production of
PGE2 in the microenvironment surrounding the tumour cells.
Regardless of whether this is so or not, it is nonetheless an
important finding that anti-tumour effector cells may convert
benign tumour cells into more malignant ones.
We have previously reported that oxygen radicals are
involved in the mechanisms responsible for PGE2 production
by tumour cells (Okada et al., 1992). Results indicated that
oxygen radicals might play a role in the in vivo malignant
progression of QR-32 cells (Okada et al., 1993). We observed
in the present study that enhanced PGE2 production by
QR-32 cells after co-culture with anti-tumour effector cells
was inhibited in the presence ofradical scavengers. We found
that oxygen radicals produced by host effector cells induce
somatic mutations in QR-32 cells (Okada et al., 1993). How-
ever, the oxygen radicals produced by LAK cells do not seem
to be enough to kill QR-32 cells, as we found when we added
radical scavengers extracellularly to the co-culture system.
Therefore, we speculate that the quantity of oxygen radicals
required to alter tumour properties is much smaller than the
quantity necessary for direct tumour cell killing.
We have observed that QR-32 cells can also be altered to
produce large amounts of PGE2 when they are cultured with
cytotoxic cytokines in the absence of anti-tumour effector
cells. This finding is a strong indication that high levels of
PGE2 production are caused mainly by the tumour cells
themselves. We wish to conclude that the factors which
stimulate PGE2 production by tumour cells are derived from
anti-tumour effector cells and not from tumour cells
themselves. Our findings lead us to suggest that an in vitro
experimental system using QR-32 cells may be useful for the
detection of tumour progression-enhancing factor(s).
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